DIRECT REPROGRAMMING OF A HUMAN SOMATIC CELL TO A SELECTED (PREDETERMINED) DIFFERENTIATED CELL WITH FUNCTIONALIZED NANOPARTICLES - Patent 3463383

(19)

(11)

EP 3 463 383 A1

(12)

(43)	Date of publication:
	10.04.2019 Bulletin 2019/15

(21)	Application number: 17807622.0

(22)	Date of filing: 02.06.2017

(51)

International Patent Classification (IPC):

A61K 31/7052^(2006.01)
A61K 38/02^(2006.01)
A61K 47/66^(2017.01)

A61K 31/7105^(2006.01)
A61K 47/55^(2017.01)

(86)	International application number:
	PCT/US2017/035823

(87)	International publication number:
	WO 2017/210638 (07.12.2017 Gazette 2017/49)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

03.06.2016 US 201662345360 P

(71)	Applicant: Stemgenics, Inc.
	Seattle, WA 98103 (US)

(72)	Inventor:
	APRIKYAN, Andranik Andrew Seattle WA 98103 (US)

(74)	Representative: MacLean, Martin Robert
	Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG The Shard 32 London Bridge Street London SE1 9SG (GB)

(54)	DIRECT REPROGRAMMING OF A HUMAN SOMATIC CELL TO A SELECTED (PREDETERMINED) DIFFERENTIATED CELL WITH FUNCTIONALIZED NANOPARTICLES